Kikuchi S, Inaba Y, Wada O, Miki K, Tenjin H, Kaneko E, Mizukoshi H
Department of Epidemiology and Environmental Health, Juntendo University School of Medicine, Tokyo, Japan.
Int J Epidemiol. 1995 Apr;24(2):346-53. doi: 10.1093/ije/24.2.346.
The influence of smoking on serum pepsinogen I has been assessed. However, still to be assessed are the influences of smoking on pepsinogen II and drinking on serum pepsinogens.
Data were collected from 13,381 employees by questionnaire and serum tests. Multiple regression analyses were done with logarithms of serum pepsinogen I (LPI), pepsinogen II (LPII) or pepsinogen I/II ratio (LI/II) as a criterion variable and as categorized explanatory variables, sex, age, subjective symptoms in the stomach, past history of peptic ulcer, current smoking dose, past smoking amount, drinking habit and current drinking dose.
Current smoking dose showed dose-dependent positive associations with LPI and LI/II: Past smoking amount yielded weakly dose-dependent negative associations with LPI and LI/II: Current drinking dose showed dose-dependent negative associations with LPI and LPII.
Current smoking elevates pepsinogen I and the I/II ratio, and it may be necessary to consider the effect of smoking when pepsinogens are used as markers for gastric cancer. Drinking reduced pepsinogen I and II, but the effect was not so large.
吸烟对血清胃蛋白酶原I的影响已得到评估。然而,吸烟对胃蛋白酶原II的影响以及饮酒对血清胃蛋白酶原的影响仍有待评估。
通过问卷调查和血清检测收集了13381名员工的数据。以血清胃蛋白酶原I(LPI)、胃蛋白酶原II(LPII)或胃蛋白酶原I/II比值(LI/II)的对数作为标准变量,并将性别、年龄、胃部主观症状、消化性溃疡病史、当前吸烟剂量、既往吸烟量、饮酒习惯和当前饮酒剂量作为分类解释变量进行多元回归分析。
当前吸烟剂量与LPI和LI/II呈剂量依赖性正相关;既往吸烟量与LPI和LI/II呈弱剂量依赖性负相关;当前饮酒剂量与LPI和LPII呈剂量依赖性负相关。
当前吸烟会升高胃蛋白酶原I和I/II比值,在将胃蛋白酶原用作胃癌标志物时,可能有必要考虑吸烟的影响。饮酒会降低胃蛋白酶原I和II,但影响不大。